BioCentury
ARTICLE | Management Tracks

Rodino-Klapac replacing O’Neill as Sarepta’s R&D head

Plus: Lassen, Apollo, Blade, CellProthera and more

November 19, 2021 12:40 AM UTC

Louise Rodino-Klapac will take on the role of head of R&D at Sarepta Therapeutics Inc. (NASDAQ:SRPT) on Dec. 1, adding to her current responsibilities as EVP and CSO. Gilmore ...



Access this Article